Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Archana Radhakrishnan"'
Autor:
Ted A. Skolarus, Sarah T. Hawley, Jane Forman, Anne E. Sales, Jordan B. Sparks, Tabitha Metreger, Jennifer Burns, Megan V. Caram, Archana Radhakrishnan, Lesly A. Dossett, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Jennifer Dunsmore, Steven Maclennan, Sameer Saini, Brent K. Hollenbeck, Vahakn Shahinian, Daniela A. Wittmann, Varad Deolankar, S. Sriram
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-13 (2024)
Abstract Background Many men with prostate cancer will be exposed to androgen deprivation therapy (ADT). While evidence-based ADT use is common, ADT is also used in cases with no or limited evidence resulting in more harm than benefit, i.e., overuse.
Externí odkaz:
https://doaj.org/article/edf770c1937947e5bba9b2a128e51551
Autor:
Lalita Subramanian, Sarah T. Hawley, Ted A. Skolarus, Aaron Rankin, Michael D. Fetters, Karla Witzke, Jason Chen, Archana Radhakrishnan
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Prostate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low‐risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive t
Externí odkaz:
https://doaj.org/article/da6b74f05abb426eb71b3b84c4a01cf8
Autor:
Christina Hunter Chapman, Megan E. V. Caram, Archana Radhakrishnan, Alexander Tsodikov, Curtiland Deville, Jennifer Burns, Alexander Zaslavsky, Michael Chang, John T. Leppert, Timothy Hofer, Anne E. Sales, Sarah T. Hawley, Brent K. Hollenbeck, Ted A. Skolarus
Publikováno v:
Cancer Medicine, Vol 8, Iss 18, Pp 7903-7912 (2019)
Abstract Background Although prostate‐specific antigen (PSA) testing is used for prostate cancer detection and posttreatment surveillance, thresholds in these settings differ. The screening cutoff of 4.0 ng/mL may be inappropriately used during pos
Externí odkaz:
https://doaj.org/article/9969c262f1ef4d6a8305c4bc204e4b20
Autor:
Archana Radhakrishnan, Jennifer Henry, Kevin Zhu, Sarah T. Hawley, Brent K. Hollenbeck, Timothy Hofer, Daniela A. Wittmann, Anne E. Sales, Ted A. Skolarus
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2686-2702 (2019)
Abstract Background With over 3 million US prostate cancer survivors, ensuring high‐quality, coordinated cancer survivorship care is important. However, implementation of recommended team‐based cancer care has lagged, and determinants of quality
Externí odkaz:
https://doaj.org/article/d7651a3bd8a04a4da22c0e407dd28f27
Autor:
Craig Evan Pollack, Michelle E Ross, Katrina Armstrong, Charles C Branas, Karin V Rhodes, Justin E Bekelman, Alicia Wentz, Christian Stillson, Archana Radhakrishnan, Enny Oyeniran, David Grande
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164411 (2016)
Prior work suggests that access to health care may influence the diagnosis and treatment of prostate cancer. Mystery-caller methods have been used previously to measure access to care for health services such as primary care, where patients' self-ini
Externí odkaz:
https://doaj.org/article/619fdd1932bb4ab2a20b9e17547d451b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Archana, Radhakrishnan, Lauren P, Wallner, Ted A, Skolarus, Arvin K, George, Bradley H, Rosenberg, Paul, Abrahamse, Sarah T, Hawley
Publikováno v:
Journal of Urology. 208:600-608
Men on active surveillance for favorable-risk prostate cancer do not receive all the recommended testing. Reasons for variation in receipt are unknown.We combined prospective registry data from the Michigan Urological Surgery Improvement Collaborativ
Autor:
Lawrence C. An, Joan Gargaro, Paul Abrahamse, Megan Mullins, Jennifer J. Griggs, Archana Radhakrishnan, Sarah T. Hawley, John Z. Ayanian, Lauren P. Wallner, Anne E. Sales, Anne F. Schott, Steven J. Katz
Publikováno v:
Breast Cancer Res Treat
PURPOSE: We developed and tested a multi-level intervention, ConnectedCancerCare (CCC), which includes a tailored website and appointment reminder system for women with early-stage breast cancer and a provider summary letter sent to their medical onc
Autor:
Ted A. Skolarus, Paul Abrahamse, Sarah T. Hawley, Steven J. Katz, Adam S Kollipara, Lauren P. Wallner, Archana Radhakrishnan
Publikováno v:
J Gen Intern Med
BACKGROUND: Primary care provider’s (PCP) role in cancer care is expanding and may include supporting patients in their treatment decisions. However, the degree to which PCPs engage in this role for low-risk prostate cancer is unknown. OBJECTIVE: C